title: Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.
abstract: Nipah virus (NiV) and Hendra virus (HeV) are emerging zoonotic viruses and the causative agents of severe respiratory disease and encephalitis in humans. Little is known about the mechanisms that govern the development of respiratory and neurological disease. Using a hamster model of lethal NiV and HeV infection, we describe the role of the route and dose of infection on the clinical outcome and determine virus tropism and host responses following infection. Infection of hamster with a high dose of NiV or HeV resulted in acute respiratory distress. NiV initially replicated in the upper respiratory tract epithelium, whereas HeV initiated infection primarily in the interstitium. In contrast, infection with a low dose of NiV or HeV resulted in the development of neurological signs and more systemic spread of the virus through involvement of the endothelium. The development of neurological signs coincided with disruption of the blood-brain barrier (BBB) and expression of tumor necrosis alpha (TNF-α) and interleukin 1 β (IL-1β). In addition, interferon-inducible protein 10 (IP-10) was identified as playing an important role in NiV and HeV pathogenesis. These studies reveal novel information on the development and progression of NiV and HeV clinical disease, provide a mechanism for the differences in transmission observed between NiV and HeV outbreaks, and identify specific cytokines and chemokines that serve as important targets for treatment.
authors: Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA. barry.rockx@utmb.edu
authors: Barry
authors: B
authors: Rockx
authors: Douglas
authors: D
authors: Brining
authors: Joshua
authors: J
authors: Kramer
authors: Julie
authors: J
authors: Callison
authors: Hideki
authors: H
authors: Ebihara
authors: Keith
authors: K
authors: Mansfield
authors: Heinz
authors: H
authors: Feldmann
references: J Virol. 2008 Sep;82(17):8721-32
references: 18579604
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3455-60
references: 19218453
references: Med J Aust. 1995 Jun 19;162(12):642-5
references: 7603375
references: Am J Pathol. 2002 Dec;161(6):2153-67
references: 12466131
references: Virus Res. 2008 Apr;133(1):13-9
references: 17374415
references: Vaccine. 2008 Jul 23;26(31):3842-52
references: 18556094
references: Southeast Asian J Trop Med Public Health. 2000 Jun;31(2):301-6
references: 11127330
references: Lancet. 1999 Oct 9;354(9186):1257-9
references: 10520635
references: Emerg Infect Dis. 2010 Feb;16(2):338-40
references: 20113576
references: Emerg Infect Dis. 2007 Jul;13(7):1031-7
references: 18214175
references: Epidemiol Infect. 2010 Nov;138(11):1630-6
references: 20380769
references: Emerg Infect Dis. 2004 Dec;10(12):2082-7
references: 15663842
references: PLoS Pathog. 2009 Oct;5(10):e1000642
references: 19888339
references: Am J Pathol. 2010 Apr;176(4):1614-8
references: 20167867
references: J Immunol Methods. 2011 May 31;368(1-2):24-35
references: 21334343
references: Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L3-15
references: 15591040
references: J Clin Virol. 2008 Dec;43(4):396-400
references: 18835214
references: J Infect Dis. 2000 May;181(5):1760-3
references: 10823780
references: Emerg Infect Dis. 2008 Oct;14(10):1526-32
references: 18826814
references: Emerg Infect Dis. 2006 Feb;12(2):235-40
references: 16494748
references: Lancet. 1997 Jan 11;349(9045):93-5
references: 8996421
references: J Infect Dis. 2000 May;181(5):1755-9
references: 10823779
references: Eur J Clin Invest. 2006 Jul;36(7):447-58
references: 16796601
references: Emerg Infect Dis. 2010 Feb;16(2):219-23
references: 20113550
references: Clin Infect Dis. 2009 Dec 1;49(11):1743-8
references: 19886791
references: Neuropathol Appl Neurobiol. 2009 Jun;35(3):296-305
references: 19473296
references: PLoS Pathog. 2010 Oct 28;6(10):e1001168
references: 21060819
references: Thromb Haemost. 2009 Dec;102(6):1014-23
references: 19967130
references: Vet J. 2009 Sep;181(3):211-20
references: 19084436
references: Virology. 2009 May 10;387(2):459-65
references: 19328514
references: J Virol. 2005 Jun;79(12):7528-34
references: 15919907
references: J Virol. 2004 Jan;78(2):834-40
references: 14694115
references: J Virol. 2010 Oct;84(19):9831-9
references: 20660198
references: Am J Pathol. 2003 Nov;163(5):2127-37
references: 14578210
references: Vet J. 2000 Nov;160(3):169-76
references: 11061954
references: J Virol. 2009 Jul;83(14):7062-74
references: 19420084
references: Arch Virol. 1999;144(4):675-85
references: 10365160
references: PLoS One. 2010 May 18;5(5):e10690
references: 20502528